Company: NDRA
Filing Date: 2025-11-26
Form Type: 424B4
Source: 0001213900-25-115097
Chunk: 29

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-11-26
Form: 424B4
Chunk 29
---
 description
summarizes the material terms of our capital stock. We are a Delaware company and our affairs are governed by our Fourth Amended and
Restated Certificate of Incorporation, as amended (our “Certificate of Incorporation”) and Amended and Restated Bylaws (our
“Bylaws”), the Delaware General Corporation Law (the “DGCL”), and the common law of the State of Delaware.

Common Stock

We currently have authority
to issue 20,000,000 shares of our common stock, par value of $0.0001per share. As of October 16, 2025, 1,166,441 shares
of our common stock were issued and outstanding, held of record by 131 stockholders. Our authorized but unissued shares of common
stock are available for issuance without further action by our stockholders, unless such action is required by applicable law or the
rules of any stock exchange or automated quotation system on which our securities may be listed or traded.

Voting Rights

Each holder of our common
stock is entitled to one vote for each such share outstanding in the holder’s name. No holder of common stock is entitled to cumulate
votes in voting for directors.

Dividend and Liquidation Rights

The holders of outstanding
shares of our common stock are entitled to such dividends as may be declared by our board of directors out of funds legally available
for such purpose. The shares of our common stock are neither redeemable nor convertible. Holders of our common stock have no preemptive
or subscription rights to purchase any of our securities. In the event of our liquidation, dissolution or winding up, the holders of
our common stock are entitled to receive pro rata our assets, which are legally available for distribution, after payments of all debts
and other liabilities. All of the outstanding shares of our common stock are fully paid and non-assessable.

We have never paid any cash
dividends on our common stock.

Certain Anti-Takeover Provisions of Delaware Law

The provisions of Delaware
law, the Certificate of Incorporation and the Bylaws could have the effect of delaying, deferring or discouraging another person from
acquiring control of us. These provisions, which are summarized below, may have the effect of discouraging takeover bids. They are also
designed, in part, to encourage persons seeking to acquire control of us to negotiate first with our board of directors. We believe that
the benefits of increased protection of our potential ability to